Regencell bioscience holdings limited
Biotechnology:-Biological-Products-(No-Diagnostic-Substances)
RGC
First Commercial Building
Causeway Bay , KY1-1107
Causeway Bay , KY1-1107
Executive/
Director
Links
Price
- Last Close
-
$ 5.75
$ -0.22 -3.69 %
Dec 10, 2024
- 52-Week High/Low
- $18.07 - $2.44
- YTD
- -38.6%
- Trading Volume
- 7,506
- Market Cap Full
- $ 74.8M
- Shares Outstanding
-
13M
Jun 30, 2023
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | - | - | - | - | - | - | -34.1% | -4.9% | -47.7% |
| Q2 | - | - | - | - | - | - | - | 61.7% | -12.9% | -1% |
| Q3 | - | - | - | - | - | - | 113% | -8.1% | -35.5% | - |
| Q4 | - | - | - | - | - | - | 45.2% | -14.5% | -36.8% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -14.2% | -15.9% | -27.4% | -18.4% | - | - | - | - | - | - | - | - |
| 2023 | 6.6% | -4.6% | -6.5% | 1.4% | -22.8% | 11.2% | -15.7% | -13.2% | -13.8% | 2.1% | -25.7% | -13.3% |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -16% | -66% | -39% |
Earnings
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Q1 | - | - | - | - |
| Q2 | - | - | - | - |
| Q3 | - | - | - | - |
| Q4 | - | - | - | - |
| A | -0.1 | -0.1 | -0.6 | -0.5 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Mar | - | - | - |
| Jun | 10 | 13 | 13 |
| Sep | - | - | - |
| Dec | - | - | - |
Annual
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Management | ||||||||||||||||||
| Inventory / Stock Turnover | - | - | - | - | - | |||||||||||||
| Total Asset Turnover | - | - | - | - | - | |||||||||||||
| Fixed Asset Turnover | - | - | - | - | - | |||||||||||||
| Leverage | ||||||||||||||||||
| Debt Ratio | - | - | - | - | - | |||||||||||||
| Debt – Equity Ratio | - | - | - | - | - | |||||||||||||
| Interest Coverage | 8 | - | - | - | - | |||||||||||||
| Equity multiplier | 0.1 | - | - | - | - | |||||||||||||